Well the heading sounds promising!
- Forums
- ASX - By Stock
- NEU
- Ann: Trofinetide significant clinical benefit in Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.64%
!
$16.75

Ann: Trofinetide significant clinical benefit in Rett syndrome, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.75 |
Change
0.270(1.64%) |
Mkt cap ! $2.114B |
Open | High | Low | Value | Volume |
$16.65 | $16.80 | $16.33 | $634.2K | 38.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 125 | $16.74 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.75 | 12 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 87 | 16.720 |
3 | 179 | 16.710 |
6 | 441 | 16.700 |
3 | 162 | 16.690 |
3 | 174 | 16.680 |
Price($) | Vol. | No. |
---|---|---|
16.740 | 76 | 2 |
16.750 | 124 | 3 |
16.760 | 135 | 3 |
16.770 | 259 | 4 |
16.780 | 110 | 2 |
Last trade - 10.52am 29/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |